|
|
| Line 1: |
Line 1: |
| {{drugbox
| | #REDIRECT [[Disopyramide#Pharmacology]] |
| | IUPAC_name = 4-dipropan-2-ylamino-2-phenyl-2-pyridin-2-yl-butanamide
| |
| | image = Disopyramide_svg.png
| |
| | CAS_number = 3737-09-5
| |
| | ATC_prefix = C01
| |
| | ATC_suffix = BA03
| |
| | PubChem = 3114
| |
| | DrugBank = APRD00507
| |
| | C = 21 | H = 29 | N = 3 | O = 1
| |
| | molecular_weight = 339.475 g/mol
| |
| | bioavailability = High
| |
| | protein_bound = 50% to 65%<br>(concentration-dependent)
| |
| | metabolism = [[Liver|Hepatic]] ([[CYP3A4]]-mediated)
| |
| | elimination_half-life = 6.7 hours (range 4 to 10 hours)
| |
| | excretion = [[Kidney|Renal]] (80%)
| |
| | pregnancy_AU = B2
| |
| | pregnancy_US = C
| |
| | legal_UK = POM
| |
| | legal_US = Rx-only
| |
| | routes_of_administration = Oral, [[intravenous therapy|intravenous]]
| |
| }}
| |
| __NOTOC__
| |
| {{CMG}}
| |
| | |
| | |
| | |
| | |
| ==[[Disopyramide (patient information)|For patient information, click here]]==
| |
| | |
| ==Overview==
| |
| '''Disopyramide''' ([[International Nonproprietary Name|INN]], trade names '''Norpace®''' and '''Rythmodan®''') is an [[antiarrhythmic]] [[medication]]. It is a Class Ia antiarrythmic used in the treatment of [[ventricular tachycardia]]s. It has no effect on [[adrenergic receptor|alpha]] or [[adrenergic receptor|beta adrenergic receptor]]s.
| |
| | |
| ==External links==
| |
| *[http://www.rxlist.com/cgi/generic2/disopyr_cp.htm Disopyramide on RxList]
| |
| | |
| | |
| {{Antiarrhythmic agents}}
| |
| | |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Drugs]]
| |
| | |
| [[de:Disopyramid]]
| |
| [[fr:Disopyramide]]
| |
| [[hr:Diizopiramid]]
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |